Double-Blind, Multi-Center, Randomized Study to Assess the Efficacy and Safety of Velneperit (S-2367) and Orlistat Administered Individually or Combined With a Reduced Calorie Diet (RCD) in Obese Subjects

NCT01126970 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

486

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity

Interventions

DRUG: Velneperit 400 mg
DRUG: Orlistat 120 mg
DRUG: Orlistat Placebo
DRUG: Velneperit Placebo
OTHER: Reduced Calorie Diet

Sponsor

Shionogi